Patents by Inventor Steve Bartz

Steve Bartz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190018850
    Abstract: Systems and methods for visually collecting, organizing, storing and accessing information. Users can visually track information related to facilities and physical assets. Systems and methods allow users to collect and manage information for other types of objects that require the physical locations of points to data elements. Further, systems provide an organized information repository for data. Systems provide individualized or tailored communications capability between users regarding the stored data or transactions about the stored data.
    Type: Application
    Filed: July 13, 2018
    Publication date: January 17, 2019
    Inventors: Steve Bartz, Rich Byrne, Scott Jacobson, Oliver Papp
  • Patent number: 9029341
    Abstract: The present invention relates to compounds, compositions, and methods for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of HBV gene expression and/or activity, and/or modulate a HBV gene expression pathway. Specifically, the invention relates to double-stranded nucleic acid molecules including small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules that are capable of mediating or that mediate RNA interference (RNAi) against HBV gene expression.
    Type: Grant
    Filed: August 12, 2011
    Date of Patent: May 12, 2015
    Assignee: Sirna Therapeutics, Inc.
    Inventors: Steve Bartz, Duncan Brown, Michael Robinson
  • Publication number: 20130150433
    Abstract: The present invention relates to compounds, compositions, and methods for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of HBV gene expression and/or activity, and/or modulate a HBV gene expression pathway. Specifically, the invention relates to double-stranded nucleic acid molecules including small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules that are capable of mediating or that mediate RNA interference (RNAi) against HBV gene expression.
    Type: Application
    Filed: August 12, 2011
    Publication date: June 13, 2013
    Inventors: Steve Bartz, Duncan Brown, Michael Robinson